Arterial and venous thrombosis in rare congenital bleeding disorders: A critical review

Haemophilia

Volumn 12, Issue 4, 2006, Pages 345-351

  Girolami, A ^a   Ruzzon, E ^a   Tezza, F ^a   Scandellari, R ^a   Vettore, S ^a   Girolami, B ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Arterial thrombosis; Rare congenital bleeding disorders; Venous thrombosis

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD CLOTTING DISORDER; FEMALE; HUMAN; MALE; MIDDLE AGED; REVIEW; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS, INHERITED; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS; VENOUS THROMBOSIS;

EID: 34248387034     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01299.x     Document Type: Review

References (54)

1. Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: an unexpected association! Haemophilia 2004; 10: 319-26.
2. Girolami A, Randi ML, Ruzzon E, Zanon E, Girolami B. Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases. J Thromb Thromboly 2005; 20: 43-6.
3. Franchini M. Thrombotic complications in patients with hereditary bleeding disorders. Thromb Haemost 2004; 92: 298-304.
4. Lowe GD. Factor IX and thrombosis. Brit JHaematol 2001; 115: 507-13.
5. Girolami A, Tezza F, Scapin M, Vettore S, Casonato S. Arterial and venous thrombosis in patients with von Willebrand disease. J. Thromb Thromboly 2006; 21: 175-8.
6. Nakagawa K, Furusawa A, Momono S, Sasaki Y, Ujiie K. Gastrectomy for a patient with congenital factor VII deficiency-a case report]. Nippon Geka Gakkai Zasshi 1990; 91: 771-3.
7. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978; 91: 387-95.
8. Hall CA, Rapaport SI, Ames SB, Degroot JA. A clinical and family study of hereditary proconvertin (factor VII) deficiency. Am J Med 1964; 37: 172-81.
9. Mariani G, Herrmann FH, Schulman S et al. Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003; 1: 2153-8.
10. Worth LL, Hoots WK. Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant. Haemophilia 1998; 4: 757-61.
11. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine 1983; 62: 248-55.
12. Chafa O, Chellali T, Sternberg C, Reghis A, Hamladji RM, Fischer AM. Severe hypofibrinogenemia associated with bilateral ischemic necrosis of toes and fingers. Blood Coagul Fibrinoly 1995; 6: 549-52.
13. Cronin C, Fitzpatrick D, Temperley I. Multiple pulmonary emboli in a patient with afibrinogenaemia. Acta Haematol 1988; 79: 53-4.
14. de Mattia D, Regina G, Giordano P, Del Vecchio GC, Altomare M, Schettini F. Association of congenital afibrinogenemia and K-dependent protein C deficiency - a case report. Angiology 1993; 44: 745-9.
15. de Vries A, Rosenberg T, Kochwa S, Boss JH. Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. Am J Med 1961; 30: 486-94.
16. Drai E, Taillan B, Schneider S, Ferrari E, Bayle J, Dujardin P. Portal vein thrombosis revealing congenital afibrinogenemia. Presse Med 1992; 21: 1820-1.
17. Dupuy E, Soria C, Molho P et al. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res 2001; 102: 211-19.
18. Garcia-Monco JC, Fernandez Canton G, Gomez Beldarrain M. Bilateral vertebral artery dissection in a patient with afibrinogenemia. Stroke 1996; 27: 2325-2327.
19. Hanano M, Takahashi H, Itoh M, Shibata A. Coexistence of congenital afibrinogenemia and protein C deficiency in a patient. Am J Hematol 1992; 41: 57-60.
20. Ingram GI, McBrien DJ, Spencer H. Fatal pulmonary embolus in congenital fibrinopenia. Report of two cases. Acta Haematol 1966; 35: 56-62.
21. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204-6.
22. MacKinnon HH, Fekete JF. Congenital afibrinogenemia. Vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication. Can Med Assoc J 1971; 104: 597-9.
23. Molho-Sabatier P, Soria C, Legrand Ch et al. Fibrinogen-indipendent platelet aggregation responsible of arterial thrombosis in an afibrinogemic patient. Thromb Haemost 1991; 65: 850.
24. Pinninger IL, Prunty FT. Some observation on the blood clotting mechanism. The role of fibrinogen and platelets with reference to a case of congenital afibrinogenemia. Brit J Exp Pathol 1946; 27: 20-6.
25. Schuepbach RA, Meili EO, Schneider E, Peter U, Bachli EB. Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thromb Haemost 2004; 91: 1044-6.
26. Takasugi Y, Shiokawa Y, Kajikawa R et al. Mesenteric venous thrombosis in a patient with congenital afibrinogenemia and diffuse peritonitis. Ann Hematol 2005; 84: 129-30.
27. Escoffre M, Zini JM, Schliamser L et al. Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 1995; 91: 739-41.
28. Schulman S, Johnsson H, Lindmarker P. Thrombotic complications after substitution with a FVII concentrate. Thromb Haemost 1991; 66: 619.
29. Gershwin ME, Gude JK. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med 1973; 288: 141-2.
30. Shifter T, Machtey I, Creter D. Thromboembolism in congenital factor VII deficiency. Acta Haematol 1984; 71: 60-2.
31. Heikinheimo R, Reinikainen M. Congenital factor VII deficiency. Two cases in children of cousins. Thromb Diath Haemorrh 1969; 21: 245-8.
32. Solanki DL, Corn M. Thromboembolism in patients with hereditary deficiency of coagulation factors. South Med J 1980; 73: 944-6.
33. Lefrere JJ, Chaunu MP, Conard J, Horellou MH, Samama M. Congenital factor VII deficiency and cerebrovascular stroke. Lancet 1985; 2: 1006-7.
34. Brodsky JB, Burgess GE. Pulmonary embolism with factor XI deficiency. JAMA 1975; 234: 1156-7.
35. Bolton-Maggs PH, Peretz H, Butler R et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004; 2: 918-24.
36. Umeda T, Hiramaru M, Nishino T, Onchi K, Matsuda T. [A case of congenital factor XI (plasma thromboplastin antecedent) deficiency with large organized thrombus in the vena cava inferior]. Acta Hemat Jpn 1968; 31: 325-33.
37. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS. Thrombogenic potential of factor XI concentrate. Lancet 1994; 344: 748-9.
38. Humphries JE, Schlein AE, Sarembock IJ, Gonias SL. Myocardial infarction in a patient with factor XI deficiency and a lupus anticoagulant. Eur Heart J 1991; 12: 1045-7.
39. Sherer Y, Bar-Zohar D, Levy Y, Shoenfeld Y. Thromboembolic phenomena in patients with hereditary factor XI deficiency. Ann Med Interne 1998; 149: 492-4.
40. Evans G, Pasi KJ, Mehta A, Lee CA, Perry DJ. Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiency. Blood Coagul Fibrinoly 1997; 8: 437-40.
41. Gitel SN, Veron D, Schulman S. Clinical experience of a FXI concentrate: possible side effects. Thromb Haemost 1991; 65: 1157.
42. Salomon O, Steinberg DM, Dardik R et al. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003, 1: 658-61.
43. Cosgriff W, Leifer E. Factor V deficiency in hemorrhagic diathesis. JAMA 1952; 148: 462-464.
44. Manotti C, Quintavalla R, Pini M, Jeran M, Paolicelli M, Dettori AG. Thromboembolic manifestations and congenital factor V deficiency: a family study. Haemostasis 1989; 19: 331-4.
45. Miller SP. Coagulation dynamics in factor V deficiency: a family study with a note on the occurrence of thrombophlebitis. Thromb Diath Haemorrh 1965; 13: 500-15.
46. Reich NE, Hoffman GL, De Wolfe VG. Recurrent thrombophlebitis and pulmonary embolism in congenital FV deficiency. Chest 1976; 69: 113-14.
47. Almeida A, Khair K, Hann I, Liesner R. Unusual presentation of factor XIII deficiency. Haemophilia 2002; 8: 703-5.
48. Mannucci PM, Bauer KA, Santagostino E et al. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994; 84: 1314-19.
49. Girolami A, Scarano L, Saggiorato G, Girolami B, Bertomoro A, Marchiori A. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinoly 1998; 9: 557-69.
50. Girolami A, Cella G, Borsato N, Burul A, Zucchetto M, Cafiero F. La deficienza congenita del FX (fattore Stuart-Prower) progr. Medicine 1975; 31: 1-15.
51. Cooper DN, Millar DS, Wacey A, Pemberton S, Tuddenham EG. Inherited factor X deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997; 78: 161-72.
52. Girolami A, Randi ML, Tezza F, Molaro G, Girolami B. Unusual longevity in a patient with factor X Friuli coagulation disorder. Thromb Haemost 2005; 93: 385-7.
53. Girolami A, Molaro G, Falomo R. Factor X Friuli coagulation disorder. The demise of the index patient. Acta Haematol 1975; 54: 120-5.
54. Schulman S, Johnsson H, Lindmarker P. Thrombotic complications after substitution with a FVII concentrate. Thromb Haemost 1991; 66: 619.